Welcome to our dedicated page for Utime news (Ticker: WTO), a resource for investors and traders seeking the latest updates and insights on Utime stock.
UTime Limited develops, produces and sells mobile devices, smart hardware and related consumer electronics in China and overseas markets. Company updates commonly cover customer and cooperation agreements, smart health wearables, smart servers, mobile-device distribution, and the use of existing sales channels for international product expansion.
UTime news also includes operating and financial results, governance matters, and capital-structure actions involving its Class A ordinary shares. Recurring corporate disclosures address reverse stock splits or share consolidations, authorized share-capital changes, shareholder votes, and amendments to the company’s memorandum and articles of association.
UTime (NASDAQ: WTO) reported that financial, legal and operational due diligence for its proposed strategic transaction with Feixiaohao Technology is progressing smoothly. The non-binding letter of intent covers potential business integration, technology infrastructure and market expansion in Web3 data and digital infrastructure, though completion is not assured.
UTime (Nasdaq: WTO) announced a registered direct offering of 1,000,000 Class A ordinary shares (or pre-funded warrants) at $1.20 per share, expected to raise approximately $1.2 million gross. The offering is expected to close on or about May 4, 2026.
Univest Securities is sole placement agent. The offering is being made under a Form F-3 shelf registration declared effective June 10, 2024; a prospectus supplement will be filed with the SEC.
UTime (Nasdaq: WTO)/b) signed a nonbinding letter of intent to acquire 100% of Feixiaohao Technology for up to (USD 64M in shares/convertible preferred and USD 16M cash).
The deal would add Feixiaohao’s Web3 data platform, technology assets, and millions of crypto users to UTime’s hardware ecosystem, subject to definitive agreements and closing conditions.
UTime (Nasdaq: WTO) announced a 5-for-1 reverse stock split of its Class A ordinary shares, effective 8:00 a.m. ET on February 17, 2026.
The Company will trade on the Nasdaq Capital Market post-split under the existing ticker WTO with a new CUSIP G9411M140. The board approved the consolidation on January 20, 2026, shareholders ratified it at the January 26, 2026 extraordinary meeting, and related amendments to authorized share capital and the memorandum and articles were approved.
The consolidation will not change any shareholder’s percentage ownership except for minor adjustments from fractional-share treatment.
UTime (Nasdaq: WTO) reported that its Shenzhen subsidiary, Shenzhen Liandai, entered an Intentional Order Cooperation Agreement with Shenzhen Yunwei Digital for the potential supply of 500,000 GM800 smart servers, representing an estimated contract value of approximately US$50 million.
The GM800 is configured with an RK3566 chipset, 4GB RAM and 128GB storage. The agreement targets formal contract signing by mid-February 2026 and initial deliveries beginning by mid-February 2026, with performance continuing through 2027.
UTime (Nasdaq: WTO) announced that its Hong Kong subsidiary signed a commercial sales agreement worth nearly $10 million with Denver-based Tumu Vertex LLC for an initial purchase order of 50,000 smart health devices.
The order is described as 25,000 units of the UT-168 BT Blood Pressure Watch and 25,000 units of the UR08 ECG Smart Ring, with FOB Hong Kong delivery, phased payments, joint quality-control procedures, and first deliveries starting in Q1 2026. UTime highlights FDA-certified medical-grade monitoring integrated into everyday wearables and positions the deal as a strategic entry into the North American medical-grade wearable market.
UTime (Nasdaq: WTO) announced a 1-for-100 reverse stock split of its Class A ordinary shares, effective 12:01 a.m. ET on November 21, 2025. Shares will trade on a split-adjusted basis at market open on November 21, 2025 under the ticker WTO. The company said the reverse split is intended to increase the per-share trading price to help regain compliance with Nasdaq's minimum bid price requirement and to better position the stock for long-term growth and institutional participation.
No fractional shares will be issued; any fractional share resulting from the adjustment will be rounded up to the nearest whole share. Brokerages and book-entry positions will be automatically updated to reflect the reverse split.
UTime Limited (Nasdaq: WTO) said on Nov 5, 2025 that it is expanding distribution of its health-focused smart wearables to additional international markets through existing global channels and partners.
The company plans to leverage its mobile-device experience in supply chain management and product development to introduce newly launched smartwatches and smart rings overseas, targeting markets where it already has business connections and seeking new partnerships.
Management emphasized the products' combination of functional design and cost-effectiveness as competitive advantages for gaining share in international personal-health markets.
UTime (Nasdaq: WTO) announced ongoing research into applying AI to health data analysis from wearable devices on November 3, 2025. The company is developing AI algorithm models to analyze continuous physiological signals from smart watches and rings.
Key research directions include building hypertension risk assessment models that integrate blood pressure, heart rate, activity and sleep, and conducting cardiovascular trend assessments via pulse wave morphology analysis. UTime says these AI functions are intended as health insights and risk-management references, not medical diagnoses. Management framed the work as a long-term R&D investment to generate earlier, deeper user health insights.
UTime Limited (Nasdaq: WTO) on October 30, 2025 released a smart ring designed for unobtrusive nighttime and long‑term continuous health monitoring.
The ring measures skin temperature, SpO2, respiratory rate, and heart rate variability (HRV) and targets sleep quality assessment with detailed, unobtrusive sleep analysis reports. It also supports daily activity tracking and female health cycle management. Management described the ring as a complementary, discreet alternative to smartwatches for continuous monitoring in specific scenarios.